SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001193125-12-008606
Filing Date
2012-01-11
Accepted
2012-01-11 09:30:56
Documents
9
Period of Report
2012-01-10
Filing Date Changed
2012-01-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d281305d8k.htm 8-K 30795
2 FORM OF SPECIMEN PREFERRED STOCK CERTIFICATE d281305dex45.htm EX-4.5 5792
3 FORM OF CERTIFICATE OF DESIGNATIONS OF SERIES D CONVERTIBLE PREFERRED STOCK d281305dex46.htm EX-4.6 77174
4 OPINION OF ARENA'S GENERAL COUNSEL d281305dex51.htm EX-5.1 6833
5 SECURITIES PURCHASE AGREEMENT d281305dex991.htm EX-99.1 82441
6 THIRD AMENDMENT TO FACILITY AGREEMENT d281305dex992.htm EX-99.2 23463
7 EXCHANGE AGREEMENT d281305dex993.htm EX-99.3 56444
8 FORM OF WARRANT TO PURCHASE COMMON STOCK OF ARENA d281305dex994.htm EX-99.4 127462
9 PRESS RELEASE d281305dex995.htm EX-99.5 5419
  Complete submission text file 0001193125-12-008606.txt   416969
Mailing Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121 8584537200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 12521251
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1